Drug Trial Radar · NCT06156566
European Trial Into Mpox Infection
Last checked: Nov 19, 2026Latest source record: Mar 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Aug 9, 2024
Primary completion
Dec 2025
Study completion Aug 2026
Sponsor
- Lead sponsor
- Miquel EkkelenkampAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- European Clinical Research Alliance for Infectious Diseases (ECRAID); Erasmus Medical Center; Hospital Universitario La Paz; ANRS, Emerging Infectious Diseases; Universiteit Antwerpen
- First posted
- Dec 5, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized controlled double-blind clinical trial is to test the drug tecovirimat in patients with mpox (previously known as monkeypox) disease. The main questions it aims to answer are: * Is tecovirimat effective in treating mpox infection. * Is tecovirimat safe to treat patients with mpox infection. Participants will receive either the drug tecovirimat orally, 600 mg twice per day, or a matching placebo. The outcome of the infection and the side effect experienced will be compared between the two groups.
Conditions
- Monkeypox
Interventions
Tecovirimat Oral CapsuleDrug
600 mg, twice daily, 14 days.
PlaceboDrug
3 capsules, twice daily, 14 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to complete mpox lesion resolutionTime frame: 28 days
Locations
12 sites in 8 countries. Site status is shown where the registry gives one.
Cliniques Universitaires St. Luc
Brussels, Belgium · Not yet recruiting
Institute of Tropical Medicine
Antwerp, Antwerp, Belgium · Recruiting
APHP St. Louis
Paris, France · Not yet recruiting
Universitätsklinikum Bonn
Bonn, Germany · Not yet recruiting
Hospital Luigi Sacco
Milan, Italy · Not yet recruiting
Azienda Ospedaliera Universitaria Integrata Verona - AOUI Verona
Verona, Italy · Not yet recruiting
Amsterdam UMC - AMC
Amsterdam, Netherlands · Not yet recruiting
Oslo Unversity Hospital
Oslo, Norway · Not yet recruiting
Hospital de Santo António dos Capuchos
Lisbon, Portugal · Not yet recruiting
Hospital Clinico San Carlos
Madrid, Spain · Not yet recruiting
Hospital Universitario La Paz
Madrid, Spain · Not yet recruiting
Hospital Universitario Virgen Macarena
Seville, Spain · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.